Pantages Capital Acquisition
PGACR · NASDAQ
About PGACR
- Employees
- 0
- Headquarters
- Wilmington, Delaware
- Listed
- Dec 5, 2024
- Sector
- N/A
- Industry
- N/A
PGACR key statistics
- Market cap
- 32.22M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 82
- Volume
- 200
- Open price
- $0.1789
- High today
- $0.1789
- Low today
- $0.1789
- 52 Week high
- $0.3786
- 52 Week low
- $0.0953
Pantages Capital Acquisition (PGACR) at a glance
Pantages Capital Acquisition (PGACR) last traded at $0.1789, with a market cap of 32.22M and a price-to-earnings ratio of 0.00.
Volume so far is 200 shares, above the average of 82 shares a day.
Over the past year Pantages Capital Acquisition has ranged from $0.0953 to $0.3786, and now sits 30% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.